University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...
62
0
Inflammation and evasion of the immune system have been reported to be some of the new hallmarks of cancer. Notably, a high-fat diet (HFD) causes obesity and chronic inflammation, and studies conducted on mice have shown ...
13
0
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the ...
0
0
Much cancer immunotherapy research has focused on harnessing the immune system's T cells to fight tumors, "but we knew that other types of immune cells could be important in fighting cancer too," says Ashish Kulkarni at the ...
227
0
Remove tumor cells from a living organism and place them in a dish, and they will multiply even faster than before. The mystery of why this is has long stumped cancer researchers, though many have simply focused on the mutations ...
217
1
Maintaining equal growth rates in opposing limbs is crucial for animals to achieve a symmetrical adult form; what happens if something goes wrong with one limb during development? According to a study publishing June 26 in ...
58
0
A type of highly malignant brain tumour contains a large number of cells involved in the formation of new blood vessels, helping it proliferate and spread. Targeting these cells could hinder tumour growth, according to new ...
5
0
A compound that mimics the main protein in high-density lipoprotein (HDL, or "good") cholesterol significantly reduced the number of tumors in the lungs of mice, reports a team of UCLA researchers. The findings help explain ...
8
0
In research published today, Babraham Institute researchers have shown that some tumours use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second ...
7
0
Johnson and Johnson recently announced that it was halting a clinical trial for a new Alzheimer's drug after safety issues emerged. This latest failure adds to the dozens of large, costly clinical trials that have shown no ...
14
1
